NRP1 and neoplasm: Notably, a combination of anti-Nrp-1 plus anti-PD-1 did not further increase target cell killing, suggesting that cytotoxicity is mainly mediated by the Nrp-1+PD-1hi TIL subset that includes most tumour-specific effector T cells (Fig. 5d).